Anaplastic oligodendroglioma in an adolescent with Lynch syndrome

Pediatric Blood and Cancer

Volumn 60, Issue 6, 2013, Pages

  Heath, John A ^a,b   Ng, Jessica ^a   Beshay, Victoria ^c   Coleman, Lee ^a,b   Lo, Patrick ^a   Amor, David J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Hereditary non polyposis colorectal cancer (HNPCC); Lynch syndrome; MSH2; Oligodendroglioma

Indexed keywords

PROTEIN MSH2;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; CASE REPORT; GENE EXPRESSION; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

ADOLESCENT; BRAIN NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; HUMANS; MALE; MUTS HOMOLOG 2 PROTEIN; OLIGODENDROGLIOMA;

EID: 84876448071     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24424     Document Type: Article

References (12)

1. Raghavan R, Balani J, Perry A, et al. Pediatric oligodendrogliomas: A study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 2003; 62: 530-537.
2. Kreiger PA, Okada Y, Simon S, et al. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 2005; 109: 387-392.
3. Suri V, Jha P, Agarwal S, et al. Molecular profile of oligodendrogliomas in young patients. Neuro Oncol 2011; 13: 1099-1106.
4. Woods MO, Williams P, Careen A, et al. A new variant database for mismatch repair genes associated with Lynch syndrome. Human Mutat 2007; 28: 669-673.
5. Watson P, Vasen HF, Mecklin JP, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008; 123: 444-449.
6. Leung SY, Yuen ST, Chan TL, et al. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene 2000; 19: 4079-4083.
7. Lebrun C, Olschwang S, Jeannin S, et al. Turcot syndrome confirmed with molecular analysis. Eur J Neurol 2007; 14: 470-472.
8. Gylling AH, Nieminen TT, Abdel-Rahman WM, et al. Differential cancer predisposition in Lynch syndrome: Insights from molecular analysis of brain and urinary tract tumors. Carcinogenesis 2008; 29: 1351-1359.
9. Giunti L, Cetica V, Ricci U, et al. Type A microsatellite instability in pediatric gliomas as an indicator of Turcot syndrome. Eur J Human Genet 2009; 17: 919-927.
10. Chang DK, Ricciardiello L, Goel A, et al. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000; 275: 18424-18431.
11. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268.
12. Peltomaki P, Gylling A. Brain tumors and the Lynch syndrome. In management of CNS tumors edited by Miklos Garami, Publisher: In Tech ISBN 978-953-307-646-1, 2011; Chapter 15: pp. 363-382.